9 Firmen mit Ergebnissen für "mater"

ETH Entrepreneurship

https://ethz.ch/en/industry/entrepreneurship.html  

8952 Schlieren, Wagistrasse 18


 entrepreneurship@ethz.ch

Excellence in entrepreneurship at ETH Zurich is driven by world-​class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions. 

ETH Entrepreneurship

Wagistrasse 18

8952 Schlieren

85 Ergebnisse für "mater" unter ETH Entrepreneurship

[ACS Appl. Mater. Interfaces] Low Temperature Wet Confocal Nickel S...

... [ACS Appl. Mater. Interfaces] Low Temperature Wet Confocal Nickel Silicide Deposition on Silicon ... [ACS Appl. Mater. Interfaces] Low Temperature Wet Confocal Nickel Silicide Deposition on Silicon ... https://shihlab.ethz.ch/lise-news/lab-news/2017/03/acs-appl- mater-interfaces-low-temperature-wet ... [ACS Appl. Mater. Interfaces] Low Temperature Wet Confocal Nickel Silicide Deposition on Silicon ...

[J. Mater. Chem. C] Layer-Controlled Two-Dimensional Perovskites: S...

... [J. Mater. Chem. C] Layer-Controlled Two-Dimensional Perovskites: Synthesis and Optoelectronics ... [J. Mater. Chem. C] Layer-Controlled Two-Dimensional Perovskites: Synthesis and Optoelectronics ... https://shihlab.ethz.ch/lise-news/lab-news/2017/05/j- mater-chem-c-layer-controlled-two-dimensional ... [J. Mater. Chem. C] Layer-Controlled Two-Dimensional Perovskites: Synthesis and Optoelectronics ...

Mehr Ergebnisse

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

290 Ergebnisse für "mater" unter Somagenetix

Infection burden and immunological responses are equivalent for pol...

... properties. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res B Part B, 2018. Abstract The development of an ... Periodicals, Inc. J Biomed Mater Res B Part B, 2018. ... mater ... Periodicals, Inc. J Biomed Mater Res B Part B, 2018. Abstract The development of an infection is a major ... mater ...

Mehr Ergebnisse

Kuros Biosciences AG

https://kurosbio.com/  

8952 Schlieren, Wagistrasse 25

 +41 (0)44 733 4747

Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.

Kuros Biosciences AG

Wagistrasse 25

8952 Schlieren

32 Ergebnisse für "mater" unter Kuros Biosciences AG

Kuros BioSciences - A novel, tissue occlusive poly(ethylene glycol)...

... Wechsler S, Fehr D, Molenberg A, Raeber G, Schense JC, Weber FE. J Biomed Mater Res A. 2008 May;85 ... , Fehr D, Molenberg A, Raeber G, Schense JC, Weber FE. J Biomed Mater Res A. 2008 May;85(2):285-92. ...

Kuros BioSciences - Surgical Sealants

... gastrointestinal tract, lobes of the lung or of the dura mater surrounding the brain and spinal cord. Kuros ... gastrointestinal tract, lobes of the lung or of the dura mater surrounding the brain and spinal cord. Kuros ... lung or of the dura mater surrounding the brain and spinal cord. Kuros’ technology can be tailored to ... gastrointestinal tract, lobes of the lung or of the dura mater surrounding the brain and spinal cord. Kuros ...

Mehr Ergebnisse

University Hospital Zurich​, Research and Education Office

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

University Hospital Zurich​, Research and Education Office

Rämistrasse 100

8091 Zürich

10 Ergebnisse für "mater" unter University Hospital Zurich​, Research and Education Office

Slide S VII 21

... , 1.5 cm dickes Meningeom der Dura mater an der Falx (Falxmeningeom).   - Die Tumorzellen bilden ein ... -old male. Incidental postmortem finding. The meningioma of the falx of the dura mater (falx ... cm langes, 1.5 cm dickes Meningeom der Dura mater an der Falx (Falxmeningeom).   - Die Tumorzellen ... . Incidental postmortem finding. The meningioma of the falx of the dura mater (falx meningioma) is ...

Slide A IV 8

... bacterial meningitis ICD-10: G00   - Pia mater von der Hirnoberfläche teilweise ... Lichteinfall, hohes Fieber, Verwirrtheit. Autopsiepräparat   - Kleinhirn - Pia mater von der Hirnoberfläche ... teilweise abgehoben - In der Pia mater herdförmig dichte Infiltrate neutrophiler Granulozyten , die sich ...

Mehr Ergebnisse

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

82 Ergebnisse für "mater" unter University of Zurich

UZH - Institute of Anatomy - Research

... studies are: The architecture of the quadriceps tendon The venous system of the Dura Mater The femoral ... The venous system of the Dura Mater The femoral entry point in MPFL reconstruction, The accuracy of ...

UZH - Science Alumni UZH - Science Alumni UZH

... mater. We love to organize public lectures and discussion events, offer an exclusive look behind the ... students and employees of the faculty and their alma mater. We love to organize public lectures and ...

Mehr Ergebnisse

CUTISS AG

http://cutiss.swiss  

8952 Schlieren, Grabenstrasse 11

 +41 44 244 36 60
 info@cutiss.swiss

After more than 15 years of research (Tissue Biology Research Unit, University Children’s Hospital Zurich), CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDA Orphan drug designation for the treatment of burns.

CUTISS AG

Grabenstrasse 11

8952 Schlieren

3 Ergebnisse für "mater" unter CUTISS AG

Clinical Development – CUTISS

... , Mazza E. J Mech Behav Biomed Mater. 2017 May;69:85-97 Bioengineering dermo-epidermal skin grafts with ... Pensalfini M, Ehret A, Stüdeli S, Marino D, Kaech A, Reichmann E, Mazza E. J Mech Behav Biomed Mater. 2017 ...

Clinical Development – CUTISS

... , Mazza E. J Mech Behav Biomed Mater. 2017 May;69:85-97 Bioengineering dermo-epidermal skin grafts with ... Pensalfini M, Ehret A, Stüdeli S, Marino D, Kaech A, Reichmann E, Mazza E. J Mech Behav Biomed Mater. 2017 ...

Mehr Ergebnisse

InSphero AG

http://www.insphero.com  

8952 Schlieren, Wagistrasse 27

 +41 44 515049-0
 info@insphero.com

InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.

InSphero AG

Wagistrasse 27

8952 Schlieren

4 Ergebnisse für "mater" unter InSphero AG

Insphero

... engineering Walser R, Metzger W, Görg A, Pohlemann T, Menger MD, Laschke MW. Eur Cell Mater. 2013; 26:222-33 ... . Eur Cell Mater. 2013; 26:222-33. This publication highlights the use spheroids as building units for ...

Insphero

... engineering Walser R, Metzger W, Görg A, Pohlemann T, Menger MD, Laschke MW. Eur Cell Mater. 2013; 26:222-33 ... . Eur Cell Mater. 2013; 26:222-33. This publication highlights the use spheroids as building units for ...

Mehr Ergebnisse

Vivtex

https://vivtex.com/  

8952 Schlieren, Wagistrasse 13


 info@vivtex.com

Vivtex’s proprietary platform enables for the first time the use of intact gastrointestinal tract tissue for fully automated robotic testing. We use this technology to enable the development of new drugs that can be given orally instead of painful and inconvenient needle injections.

Vivtex

Wagistrasse 13

8952 Schlieren

1 Ergebnisse für "mater" unter Vivtex

Screening oral drugs for their interactions with the intestinal tra...

Screening oral drugs for their interactions with the intestinal transportome via porcine tissue expl, https://vivtex.com/wp-content/uploads/2024/05/Screening-oral-drugs-for-their-interactions.pdf,...

Roche Glycart AG

https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

Roche Glycart AG

Wagistrasse 10

8952 Schlieren

2 Ergebnisse für "mater" unter Roche Glycart AG

untitled

untitled, https://diagnostics.roche.com/content/dam/diagnostics/Blueprint/en/pdf/rmd/2014-ESC-Guidelines-on-the-diagnosis-and-management-of-acute-pulmonary-embolism.pdf, untitled ESC GUIDELINES 20...

OP-EHEA190412 1..61

OP-EHEA190412 1..61, https://diagnostics.roche.com/content/dam/diagnostics/Blueprint/en/pdf/rmd/2019-ESC-Guidelines-on-the-diagnosis-and-management-of-acute-pulmonary-embolism.pdf, OP-EHEA190412 1...

Nach oben